Evidence map›Paper›PMID 35523346›Full record

ArticleThe Science of the total environment2022

Use of illicit drugs, alcohol and tobacco in Spain and Portugal during the COVID-19 crisis in 2020 as measured by wastewater-based epidemiology.

Andrea Estévez-Danta, Lubertus Bijlsma, Ricardo Capela, Rafael Cela, Alberto Celma, Félix Hernández, Unax Lertxundi, João Matias, Rosa Montes, Gorka Orive and 4 more

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The Science of the total environment, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
5.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 3 countries.

Andrea Estévez-DantaDepartment of Analytical Chemistry, Nutrition and Food Sciences, Institute of Research on Chemical and Biological Analysis (IAQBUS), Universidade de Santiago de Compostela, Constantino Candeira S/N, 15782 Santiago de Compostela, Spain.
Lubertus BijlsmaEnvironmental and Public Health Analytical Chemistry, Research Institute for Pesticides and Water, University Jaume I, Avda Sos Baynat s/n, 12071 Castellón, Spain.
Ricardo CapelaCIMAR/CIIMAR, Interdisciplinary Centre of Marine and Environmental Research, Group of Endocrine Disrupter and Emerging Contaminants, University of Porto, Avenida General Norton de Matos s/n, 4450-208 Matosinhos, Portugal; FCUP-Department of Biology, Faculty of Sciences, University of Porto, Rua Do Campo Alegre, 4169-007 Porto, Portugal.
Rafael CelaDepartment of Analytical Chemistry, Nutrition and Food Sciences, Institute of Research on Chemical and Biological Analysis (IAQBUS), Universidade de Santiago de Compostela, Constantino Candeira S/N, 15782 Santiago de Compostela, Spain.
Alberto CelmaEnvironmental and Public Health Analytical Chemistry, Research Institute for Pesticides and Water, University Jaume I, Avda Sos Baynat s/n, 12071 Castellón, Spain.
Félix HernándezEnvironmental and Public Health Analytical Chemistry, Research Institute for Pesticides and Water, University Jaume I, Avda Sos Baynat s/n, 12071 Castellón, Spain.
Unax LertxundiBioaraba Health Research Institute, Osakidetza Basque Health Service, Araba Mental Health Network, Araba Psychiatric Hospital, Pharmacy Service, c/Alava 43, 01006 Vitoria-Gasteiz, Alava, Spain.
João MatiasEuropean Monitoring Centre for Drugs and Drug Addiction, 1249-289 Lisbon, Portugal.
Rosa MontesDepartment of Analytical Chemistry, Nutrition and Food Sciences, Institute of Research on Chemical and Biological Analysis (IAQBUS), Universidade de Santiago de Compostela, Constantino Candeira S/N, 15782 Santiago de Compostela, Spain.
Gorka OriveNanoBioCel Group, Laboratory of Pharmaceutics, School of Pharmacy, University of the Basque Country UPV/EHU, Paseo de la Universidad 7, Vitoria-Gasteiz 01006, Spain; Biomedical Research Networking Centre in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Vitoria-Gasteiz, Spain; University Institute for Regenerative Medicine and Oral Implantology - UIRMI (UPV/EHU-Fundación Eduardo Anitua), Vitoria-Gasteiz, Spain; Singapore Eye Research Institute, The Academia, 20 College Road, Discovery Tower, Singapore; Bioaraba, NanoBioCel Research Group, Vitoria-Gasteiz, Spain.
Ailette PrietoDepartment of Analytical Chemistry, Faculty of Science and Technology, University of the Basque Country (UPV/EHU), Leioa, Basque Country, Spain; Research Centre for Experimental Marine Biology and Biotechnology (PIE), University of the Basque Country (UPV/EHU), Plentzia, Basque Country, Spain.
Miguel M SantosCIMAR/CIIMAR, Interdisciplinary Centre of Marine and Environmental Research, Group of Endocrine Disrupter and Emerging Contaminants, University of Porto, Avenida General Norton de Matos s/n, 4450-208 Matosinhos, Portugal; FCUP-Department of Biology, Faculty of Sciences, University of Porto, Rua Do Campo Alegre, 4169-007 Porto, Portugal.
Rosario RodilDepartment of Analytical Chemistry, Nutrition and Food Sciences, Institute of Research on Chemical and Biological Analysis (IAQBUS), Universidade de Santiago de Compostela, Constantino Candeira S/N, 15782 Santiago de Compostela, Spain. Electronic address: rosario.rodil@usc.es.
José Benito QuintanaDepartment of Analytical Chemistry, Nutrition and Food Sciences, Institute of Research on Chemical and Biological Analysis (IAQBUS), Universidade de Santiago de Compostela, Constantino Candeira S/N, 15782 Santiago de Compostela, Spain. Electronic address: jb.quintana@usc.es.
Universidade de Santiago de Compostela · ESUniversidade do Porto · PTBTI Biotechnology Institute · ESEuropean Monitoring Centre for Drugs and Drug Addiction · PTHospital Universitario Araba · ESUniversity of the Basque Country · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The COVID-19 pandemic spread rapidly worldwide in the year 2020, which was initially restrained by drastic mobility restrictions. In this work, we investigated the use of illicit drugs (amphetamine, methamphetamine, ecstasy, cocaine and cannabis), and licit substances of abuse (alcohol and tobacco) during the earlier months (March-July 2020) of the pandemic restrictions in four Spanish (Bilbao and its metropolitan area, Vitoria-Gasteiz, Castellón and Santiago de Compostela) and two Portuguese (Porto and Vila do Conde) locations by wastewater-based epidemiology (WBE). The results show that no methamphetamine was detected in any of the locations monitored, while amphetamine use was only detectable in the two locations from the Basque Country (Bilbao and its metropolitan area and Vitoria-Gasteiz), with high estimated average usage rates (700-930 mg day

Indexed as

CocaineCOVID-19Illicit DrugsMethamphetamineN-Methyl-3,4-methylenedioxyamphetamineSubstance-Related DisordersWater Pollutants, ChemicalAmphetamineCommunicable Disease ControlHumansPandemicsPortugalSpainSubstance Abuse DetectionTobacco ProductsWastewaterAmphetamineCocaineIllicit DrugsMethamphetamineN-Methyl-3,4-methylenedioxyamphetamineWastewaterWater Pollutants, ChemicalCoronavirusDrugs of abuseEthanolLockdownNicotineWastewater surveillance

Identifiers

PMID35523346
PMCPMC9065690
OpenAlexW4225415742

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.